A new single-shot rabies vaccine shows promising results in protecting against the disease, early research suggests. Phase 1 clinical trial results have also indicated that the jab is safe.
The new vaccine aims to address some of the main problems with existing rabies vaccines, which is that they are expensive and require multiple doses. Researchers say it could help prevent thousands of deaths from the disease every year.
Associate Professor Sandy Douglas, chief investigator of the trial at the Jenner Institute, University of Oxford, said: “We’re absolutely delighted with these early results – the vaccine has performed even better than we had expected. The problems with existing rabies vaccines are that they are expensive and require multiple doses.
